Nevada Desert more Valuable than Wall Street or Silicon Valley?
It could be true, according to Nevada Governor Steve Sisolak. The state's desert flats contain more lithium than any other geography in the world. And with electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar.
Find Out How to Take Advantage of Nevada's Lithium

LDX Insider Trading (Lumos Diagnostics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Lumos Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Lumos Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lumos Diagnostics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/29/2021 11:06 AM ET

This chart shows the closing price history over time for LDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Invest in Artificial Intelligence Before It Changes the World
A.I. is going to be one of the dominant themes over the next decade, as companies automate their businesses and use A.I. to remain competitive. This is the golden age of investing in artificial intelligence!
Invest in this red-hot industry at pre-IPO prices.

Lumos Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/28/2021Robert SamburskyInsiderIssued24,000A$1.25A$30,000.00
See Full Table
The Last Great Value Stock
Last year it was more profitable than Disney, Square or even Tesla.

But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.

SEC Filings (Institutional Ownership Changes) for Lumos Diagnostics (ASX:LDX)

Lumos Diagnostics Holdings Limited operates as an integrated developer and manufacturer of point-of-care (POC) diagnostic tests. The company develops and manufactures proprietary and in-licensed POC diagnostic tests. Its products include FebriDx, a test that differentiates between bacterial and viral respiratory infections; ViraDx, a combined COVID/Influenza test for acute respiratory infections; and CoviDx, an antigen test for COVID-19. The company also engages in the contract research and development services specialized in the innovation, development, commercialization, and manufacturing of point-of-care diagnostic solutions for clinical and consumer applications. It offers its products through distributors primarily in the North American and European markets. The company was founded in 2004 and is headquartered in Melbourne, Australia.
Read More on Lumos Diagnostics

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Lumos Diagnostics?

Lumos Diagnostics' top insider investors include:
  1. Robert Sambursky (Insider)
Learn More about top insider investors at Lumos Diagnostics.
Copper More Critical than Lithium?
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found.
See How To Can Benefit From New Copper Discoveries